BEGIN:VCALENDAR
VERSION:2.0
PRODID:-//RE4CH - ECPv6.1.2.2//NONSGML v1.0//EN
CALSCALE:GREGORIAN
METHOD:PUBLISH
X-ORIGINAL-URL:https://www.research-for-children.de
X-WR-CALDESC:Events for RE4CH
REFRESH-INTERVAL;VALUE=DURATION:PT1H
X-Robots-Tag:noindex
X-PUBLISHED-TTL:PT1H
BEGIN:VTIMEZONE
TZID:Europe/Berlin
BEGIN:DAYLIGHT
TZOFFSETFROM:+0100
TZOFFSETTO:+0200
TZNAME:CEST
DTSTART:20200329T010000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:+0200
TZOFFSETTO:+0100
TZNAME:CET
DTSTART:20201025T010000
END:STANDARD
END:VTIMEZONE
BEGIN:VEVENT
DTSTART;TZID=Europe/Berlin:20200204T000000
DTEND;TZID=Europe/Berlin:20200204T235900
DTSTAMP:20260820T190129
CREATED:20191212T092049Z
LAST-MODIFIED:20191212T092051Z
UID:1345-1580774400-1580860740@www.research-for-children.de
SUMMARY:ERC Consolidator Grants
DESCRIPTION:Are you a scientist who wants to consolidate your independence  by establishing a research team and continuing to develop a success  career in Europe? The ERC Consolidator Grant could be for you. You can  also apply if you have recently created an independent\, excellent  research team and want to strengthen it.  \n\n\n\nResearchers of any nationality with 7-12 years of experience since completion of PhD (Extensions are possible under certain circumstances — see the latest ERC Work Programme)\, a scientific track record showing great promise and an excellent research proposal.  \n\n\n\n\n	Consolidator Grants may be awarded up to € 2 million for a period of 5 years.\n (pro rata for projects of shorter duration). However\, an additional € 1\n million can be made available to cover eligible “start-up” costs for \nresearchers moving from a third country to the EU or an associated \ncountry and/or the purchase of major equipment and/or access to large \nfacilities and/or other major experimental and field work costs. \n\n\n\nFor more information\, please see the ERC website here: https://erc.europa.eu/funding/consolidator-grants
URL:https://www.research-for-children.de/event/erc-consolidator-grants/
CATEGORIES:Funding Deadlines
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=Europe/Berlin:20200214T000000
DTEND;TZID=Europe/Berlin:20200214T235900
DTSTAMP:20260820T190129
CREATED:20191127T110107Z
LAST-MODIFIED:20191127T110514Z
UID:1300-1581638400-1581724740@www.research-for-children.de
SUMMARY:Geschlechtsspezifische Besonderheiten bei Gesundheitsförderung und Prävention in Lebenswelten
DESCRIPTION:Wissenschaftliche Erkenntnisse \nzeigen\, dass das Geschlecht sowohl Einfluss auf den Erhalt der \nGesundheit als auch auf die Entstehung von Krankheiten hat. Dies kann zu\n ungleichen Gesundheitschancen beitragen. Bislang werden \ngeschlechtsspezifische Besonderheiten bei der Entwicklung und Umsetzung \nvon Maßnahmen der Gesundheitsförderung und Prävention noch wenig \nberücksichtigt. Ein besseres Verständnis geschlechtsspezifischer \nBesonderheiten sowie Erkenntnisse zu Ursachen und Auswirkungen sind \nhierfür erforderlich. \n\n\n\nDas GKV-Bündnis für Gesundheit fördert daher\n interdisziplinäre und praxisorientierte Forschungsvorhaben\, die \ngeschlechtsspezifische Besonderheiten untersuchen und adäquate Ansätze \nfür Maßnahmen der lebensweltbezogenen Gesundheitsförderung und \nPrävention entwickeln. \n\n\n\nDas Förderangebot richtet sich an: \n\n\n\nStaatliche und nichtstaatliche (Fach-)HochschulenUniversitäre und außeruniversitäre ForschungseinrichtungenGemeinnützige Körperschaften (z. B. eingetragene Vereine\, Stiftungen und gemeinnützige GmbHs)\n\n\n\nhttps://www.gkv-buendnis.de/forschung-im-buendnis/foerderung-forschungsvorhaben/
URL:https://www.research-for-children.de/event/geschlechtsspezifische-besonderheiten-bei-gesundheitsforderung-und-pravention-in-lebenswelten/
CATEGORIES:Funding Deadlines
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=Europe/Berlin:20200215T000000
DTEND;TZID=Europe/Berlin:20200215T235900
DTSTAMP:20260820T190129
CREATED:20191212T110123Z
LAST-MODIFIED:20191212T110125Z
UID:1349-1581724800-1581811140@www.research-for-children.de
SUMMARY:Fritz Thyssen Stiftung: Molecular causes in the development of illnesses
DESCRIPTION:I n accordance with one of the desires of the donors\, special attention is  devoted by the foundation institutions to medical research. At present  the foundation is focusing its support on the field of “Molecular causes  in the development of illnesses”.  This programme supports molecular  biological studies of illnesses whose development is based on genetic  defects or with which gene variants contribute to the development of  complex illnesses.  \n\n\n\nMore information about this research focus of the Foundation can be found here: https://www.fritz-thyssen-stiftung.de/en/funding/promotion-areas/medicine-and-natural-sciences/ \n\n\n\nMore information about submitting an application can be found here: https://www.fritz-thyssen-stiftung.de/en/funding/types-of-support/support-of-projects/
URL:https://www.research-for-children.de/event/fritz-thyssen-stiftung-molecular-causes-in-the-development-of-illnesses/
CATEGORIES:Funding Deadlines
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=Europe/Berlin:20200218T000000
DTEND;TZID=Europe/Berlin:20200218T235900
DTSTAMP:20260820T190129
CREATED:20200113T082839Z
LAST-MODIFIED:20200113T122817Z
UID:1375-1581984000-1582070340@www.research-for-children.de
SUMMARY:EJP RD Joint Transnational Call: “Pre-clinical Research to Develop Effective Therapies for Rare Diseases”
DESCRIPTION:The ERA-Net E-Rare has successfully implemented ten Joint \nTransnational Calls for rare disease research projects since 2006. This \neffort continues in the framework of the European Joint Programme on Rare Diseases (EJP RD)\n that has been established to further help in coordinating the research \nefforts of European\, Associated and non-European countries in the field \nof rare diseases and implement the objectives of the International Rare Disease Research Consortium (IRDiRC). \n\n\n\nThe aim of the call is to enable scientists in different countries to build an effective collaboration on a common interdisciplinary research project based on complementarities and sharing of expertise\, with a clear future benefit for patients. \n\n\n\nThe deadline for registration and submission of pre-proposals is the 18th of February 2020.  \n\n\n\nResearch proposals must cover at least one of the following areas: \n\n\n\nDevelopment of novel therapies in a preclinical setting (including \nsmall molecules\, repurposing drugs\, cell and gene advanced therapies) \nfocusing on condition(s) with unmet medical needsUse of disease models suitable for medicinal product’s development according to EMA guidelinesDevelopment of predictive and pharmacodynamics (PD) biomarkers (with\n appropriate analytical methods e.g. OMICS) in a preclinical setting \n(e.g. in the validated model or in pre-collected human samples) for \nmonitoring the efficiency of the therapy. The model chosen must mimic \nthe human diseases and be transposable so that the biomarker identified \nin animals can be valid for humansProof of principle studies fostering an early (pre-clinical) stage \nof drug development (excluding interventional clinical trials of phase \n1-4).\n\n\n\nThe following approaches and topics are excluded from the scope of the call: \n\n\n\nTherapeutic approaches concerning rare infectious diseases\, rare  cancers and rare adverse drug events in treatments of common diseasesInterventional clinical trialsSurgery or radiation therapiesStudies that focus on research to accelerate diagnosis or to set up  new registry/cohort studies to explore disease progression and  mechanisms as these were the focus of JTC 2019.Rare neurodegenerative diseases which are within the main focus of the Joint Programming Initiative on Neurodegenerative Disease Research (JPND).  These are: Alzheimer’s disease and other dementias; Parkinson’s disease  (PD) and PD-related disorders; Prion disease; Motor Neuron Diseases;  Huntington’s disease; Spinal Muscular Atrophy and dominant forms of  Spinocerebellar Ataxia.  Interested researchers should refer to the  relevant JPND calls.       Childhood dementias/neurodegenerative diseases are not excluded.\n\n\n\nFor more information\, please visit the EJP RD webpage here.
URL:https://www.research-for-children.de/event/ejp-rd-joint-transnational-call-pre-clinical-research-to-develop-effective-therapies-for-rare-diseases/
CATEGORIES:Funding Deadlines
END:VEVENT
END:VCALENDAR